Environmental influences in cancer aetiology

Journal of Nutritional and Environmental Medicine

Volumn 15, Issue 2-3, 2005, Pages 56-114

  Newby, John A ^a   Howard, C Vyvyan ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Cancer aetiology; Cancer and the environment; Cancer incidence; Carcinogenesis; Epidemiology; Organochlorines and cancer; Persistent organic pollutants and cancer

Indexed keywords

CARCINOGEN; DIBENZOFURAN DERIVATIVE; DIOXIN; ENDOCRINE DISRUPTOR; ENVIRONMENTAL CHEMICAL; ORGANOCHLORINE DERIVATIVE; PESTICIDE; XENOBIOTIC AGENT;

BRAZIL; BREAST CARCINOMA; CANADA; CANCER INCIDENCE; CANCER PREVENTION; CANCER RESEARCH; CANCER RISK; CARCINOGENESIS; CHILDHOOD CANCER; DATA BASE; DIET; ENVIRONMENT; GENE MUTATION; GENETIC POLYMORPHISM; HORMONE RELEASE; HUMAN; MEDICAL LITERATURE; MEDLINE; METHODOLOGY; MYELOMA; NONHODGKIN LYMPHOMA; NONHUMAN; ORGANOGENESIS; PHYSICIAN; POLLUTION; PRIORITY JOURNAL; PROSTATE CARCINOMA; REVIEW; SMOKING; TESTIS CARCINOMA;

ANIMALIA; NICOTIANA TABACUM;

EID: 33646944729     PISSN: 13590847     EISSN: 13646907     Source Type: Journal    
DOI: 10.1080/13590840500535396     Document Type: Review

References (316)

1. Stewart BW, Kleihues P (eds). World cancer report. Lyon: IARC Press; 2003.
2. Shibuya K, Mathers CD, Boschi-Pinto C, Lopez AD, Murray CJL. Global and regional estimates of cancer mortality and incidence by site: II. Results for the global burden of disease 2000. BMC Cancer 2002;2:37.
3. Frankish H. 15 million new cancer cases per year by 2020, says WHO. Lancet 2003;361:1278.
4. Ferlay J, Bray F, Parkin DF, Pisani P. Globican 2000: Cancer incidence and mortality worldwide. IARC Cancer Databases No 5. Lyon: IARC Press; 2000.
5. Bray F, Sankila R, Ferlay J, Parkin DM. Estimates of cancer incidence and mortality in Europe in 1995. Eur J Cancer 2002;38:99-166.
6. Organisation for Economic Co-operation and Development. OECD Health Data, 4th Edition, 2004 (http://www.oecd.org/home/).
7. Cancer Research UK. CancerStats, Incidence - UK, April 2003 (www.cancerresearchuk.org).
8. Office for National Statistics. Data adapted from Appendix B12b age-standardised incidence rates per 100,000 population, 2003 (http://www.statistics.gov.uk/default.asp).
9. Cancer Research UK. Index to Statistics web site incidence, 2004 (http://www.cancerresearchuk.org/aboutcancer/statistics/?version=4).
10. Cancer Research UK. CancerStats, Incidence -UK, February 2004 (http://www.cancerresearchuk.org/aboutcancer/statistics/statsmisc/pdfs/ cancerstats_incidence.pdf).
11. National Cancer Institute. DevCan: Probability of developing or dying of cancer software, version 5.1. Statistical Research and Applications Branch, 2004 (http://srab.cancer.gov/devcan).
12. Birch JM, Alston RD, Kelsey AM, Quinn MJ, Babb P, McNally RJQ. Classification and incidence of cancers in adolescents and young adults in England 1979-1997. Br J Cancer 2002;87:1267-1274.
13. Stiller C. Epidemiology of cancer in adolescents. Med Pediatr Oncol 2002;39:149-155.
14. McNally RJ, Kelsey AM, Cairns DP, Taylor GM, Eden OB, Birch JM. Temporal increase in the incidence of childhood solid tumours seen in North West England (1954-1998) are likely to be real. Cancer 2002;92:1967-1976.
15. Office for National Statistics. Cancer registrations for selected cancers by gender and five-year age group for England and Wales, 1971-1999, 2003 (http://www.statistics.gov.uk/default.asp).
16. Das SK. Harmful health effects of cigarette smoking. Mol Cell Biochem 2003;253:159-165.
17. Boffetta P. Involuntary smoking and lung cancer. Scand J Work Environ Health 2002;28:30-40.
18. Doll R, Hill AB. A study of aetiology of carcinoma of the lung. Br Med J 1952;2:1271-1286.
19. Doll R, Hill AB. Smoking and carcinoma of the lung. Br Med J 1950;2:739-748.
20. Lee WJ, Hoppin JA, Blair A. Cancer incidence among pesticide applicators exposed to Alachlor in the Agricultural Health Study. Am J Epidemiol 2004;159:373-380.
21. Bodner KM, Collins JJ, Bloemen J, Carson ML. Cancer risk for chemical workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Occup Environ Med 2003;60:672-675.
22. Rodvall Y, Dich J, Wiklund K. Cancer risk in offspring of male pesticide applicators in agriculture in Sweden. Occup Environ Med 2003;60:798-801.
23. Van Maele-Fabry G, Williams JL. Occupation related pesticide exposure and cancer of the prostate: a meta-analysis. Occup Environ Med 2003;60:634-642.
24. Safi JM. Association between chronic exposure to pesticides and recorded cases of human malignancy in Gaza Governorates 1990-1999. Sci Total Environ 2002;284:75-84.
25. Mathur AV, Bhatnagar AP, Sharma RG. Breast cancer incidence and exposure to pesticides among women originating from Jaipur. Environ Int 2002;28:331-336.
26. Lichtenstein P, Holm NV, Vrkasalo PK. Environmental and heritable factors in the causation of cancer. N Engl J Med 2000;342:78-85.
27. Czene K, Lichtenstein P, Hemminki K. Environmental and heritable causes of cancer among 9.6 million individuals in the Swedish Family-Cancer Database. Int J Cancer 2002;99:260-266.
28. IARC. Tobacco smoking. IARC monographs on the evaluation of the carcinogenic risks of chemicals to humans, Vol. 38. Lyon: IARC Press; 1986.
29. Adami H-O, Trichopoulos D. Perspective: obesity and mortality from cancer. N Engl J Med 2003;348:1623-1624.
30. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003;348:1625-1638.
31. Mack WJ, Preston-Martin S, Bernstein L, Qian D. Lifestyle and other risk factors for thyroid cancer in Los Angeles County females. Ann Epidemiol 2003;21:395-401.
32. Mirvish S, Haorah J, Zhou L, Hartman M, Morris CR, Clapper ML. N-nitroso compounds in the gastrointestinal tract of rats and in the faeces of mice with induced colitis or fed hot dogs or beef. Carcinogenesis 2003;24:595-603.
33. Tuohy PG. Soy infant formula and phytoestrogens. J Paediatr Child Health 2003;39:401-405.
34. Menezes RJ, Tomlinson G, Kreiger N. Physical activity and risk of renal cell carcinoma. Int J Cancer 2003;107:642-646.
35. Ferguson LR. Natural and human-made mutagens and carcinogens in the human diet. Toxicology 2003;181-182:79-82.
36. IARC. Some naturally occurring substances: food items and constituents, heterocyclic aromatic amines and mycotoxins. IARC monographs on the evaluation of the carcinogenic risks of chemicals to humans, Vol. 56. Lyon: IARC Press; 1993.
37. World Health Organization. Global status report on alcohol. Geneva: World Health Organization; 1999.
38. IARC. Alcohol drinking. IARC monographs on the evaluation of the carcinogenic risks to humans, Vol. 44. Lyon: IARC Press; 1988.
39. IARC. Man-made vitreous fibres. IARC monographs on the evaluation of the carcinogenic risks to humans, Vol. 81. Lyon: IARC Press; 2002.
40. IARC. Asbestos. IARC monographs on the evaluation of the carcinogenic risks of chemicals to humans, Vol. 14. Lyon: IARC Press; 1977.
41. Nitta Y, Hoshi M, Kamiya K. Effects of radioactive iodine (131I) on the thyroid of newborn, pubertal and adult rats. Int Congress Series 2002;1236:127-131.
42. McGeoghegan D, Binks K. The mortality and cancer morbidity experience of workers at British Nuclear Fuels plc, 1946-1997. Int Congress Series 2002;1236:51-54.
43. Rubino C, Cailleux AF, De Vathaire F, Schlumberger M. Thyroid cancer after radiation exposure. Eur J Cancer 2002;38:645-647.
44. Berrington A, Darby SC, Weiss HA, Doll R. 100 years of observation on British radiologists: mortality from cancer and other causes 1897-1997. Br J Radiol 2001;74:507-519.
45. IARC. Ionizing radiation, Part 1: X- and gamma (g)-radiation, and neutrons. IARC monographs on the evaluation of the carcinogenic risks to humans, Vol. 75. Lyon: IARC Press; 2000.
46. IARC. Occupational exposures in petroleum refining; crude oil and major petroleum fuels. IARC monographs on the evaluation of the carcinogenic risks of chemicals to humans, Vol. 45. Lyon: IARC Press; 1989.
47. Alguacil J, Porta M, Kauppinen T. Occupational exposure to dyes, metals, polycyclic aromatic hydrocarbons and other agents and k-ras activation in human exocrine pancreatic cancer. Int J Cancer 2003;107:635-641.
48. Gago-Dominguez M, Bell D, Watson M, Yuan JM, Castelao JE, Hein DW, Chan KK, Coetzee GA, Ross RK, Yu MC. Permanent hair dyes and bladder cancer: risk modification by cytochrome P4501A2 and N-acetyltransferases 1 and 2. Carcinogenesis 2003;24:483-489.
49. Gago-Dominguez M, Esteban Castelao J, Yuan J-M, Yu MC, Ross RK. Use of permanent hair dyes and bladder-cancer risk. Int J Cancer 2001;91:575-579.
50. IARC. Occupational exposures of hairdressers and barbers and personal use of hair colourants; some hair dyes, cosmetic colourants, industrial dyestuffs and aromatic amines. IARC monographs on the evaluation of the carcinogenic risks of chemicals to humans, Vol. 57. Lyon: IARC Press; 1993.
51. Zheng T, Zahm SH, Cantor KP, Weisenburger DD, Zhang Y, Blair A. Agricultural exposure to carbamate pesticides and risk of non-Hodgkin lymphoma. J Occup Environ Med 2001;43:641-649.
52. IARC. Some organochlorine pesticides. IARC monographs on the evaluation of the carcinogenic risks of chemicals to humans, Vol. 5. Lyon: IARC Press; 1973.
53. Bosetti C, Negril E, Fattore E, La Vecchia C. Occupational exposure to polychlorinated biphenyls and cancer risk. Eur J Cancer Prev 2003;12:251-255.
54. IARC. Polychlorinated biphenyls and polybrominated biphenyls. IARC monographs on the evaluation of the carcinogenic risks of chemicals to humans, Vol. 18. Lyon: IARC Press; 1978.
55. IARC. Some antiviral and antineoplastic drugs, and other pharmaceutical agents. IARC monographs on the evaluation of the carcinogenic risks to humans, Vol. 76. Lyon: IARC Press; 2000.
56. IARC. Hormonal contraception and post-menopausal hormonal therapy. IARC monographs on the evaluation of the carcinogenic risks to humans, Vol. 72. Lyon: IARC Press; 1999.
57. Darby S, Hill D, Doll R. Radon: a likely carcinogen at all exposures. Ann Oncol 2001;12:1341-1351.
58. Doll R. Effects of small doses of ionising radiation. J Radiol Prot 1999;19:63-65.
59. Lubin JH, Boice JD. Lung cancer risk from residential radon: a meta analysis of eight epidemiologic studies. Natl Cancer Inst 1997;89:49-57.
60. Dickinson HO, Nyari TA, Parker L. Childhood solid tumours in relation to infections in the community in Cumbria during pregnancy and around the time of birth. Br J Cancer 2002;87:746-750.
61. McNally RJQ, Cairns DP, Eden OE, Alexander FE, Taylor GM, Kelsey AM, Birch JM. An infectious aetiology for childhood brain tumours? Evidence from space-time clustering and seasonality analyses. Br J Cancer 2002;86:1070-1077.
62. Birch JM, Alexander FE, Blair V, Eden OB, Taylor GM, McNally RJ. Space-time clustering patterns in childhood leukaemia support a role for infection. Br J Cancer 2000;82:1571-1575.
63. IARC. Epstein-Barr virus and Kaposi's sarcoma herpesvirus/human herpesvirus 8. IARC monographs on the evaluation of the carcinogenic risks to humans, Vol. 70. Lyon: IARC Press; 1997.
64. US Environmental Protection Agency. Childhood cancer. America's children and the environment. Measures of contaminants, body burdens and illness. US Environmental Protection Agency. EPA 240-R-03-001; 2003, pp 76-81.
65. Howard CV, Newby JA. Could the increase in cancer incidence be related to recent environmental changes? In: Nicolopoulou-Stamati P, Hens L, Howard CV, Van Larenbeke L, editors. Cancer as an environmental disease. Dordrecht: Kluwer; 2004.
66. Perera F, Hemminki K, Jedrychowski W, Whyatt R, Campbell U, Hsu Y, Santella R, Albertini R, O'Neill JP. In utero DNA damage from environmental pollution is associated with somatic gene mutation in newborns. Cancer Epidemiol Biomark Prev 2002;11:134-137.
67. Soloman G, Schetter T. Environment and health: 6. Endocrine disruption and potential human health indications. Can Med Assoc J 2000;163:1471-1476.
68. Howard CV. Synergistic effects of chemical mixtures - can we rely on traditional toxicology? Ecologist 1997;27:192-195.
69. Ward MH, Mark SD, Cantor KP, Weisenburger DD, Correa-Villasenor A, Zahm SH. Drinking water nitrate and the risk of non-Hodgkin's lymphoma. Epidemiology 1996;7:465-471.
70. Weisenburger DD. Environmental epidemiology of non-Hodgkin's lymphoma in eastern Nebraska. Am J Ind Med 1990;18:303-305.
71. BBC News. Cancer cases 'at all-time high', 2004 (http://news.bbc.co.uk/1/ hi/health/3373447.stm).
72. Camplejohn RS, Gilchrist R, Easton D, McKenzie-Edwards E, Barnes DM, Eccles DM, Ardern-Jones A, Hodgson SV, Duddy PM, Eeles RA. Apoptosis, ageing and cancer susceptibility. Br J Cancer 2003;88:487-490.
73. Jemal A, Thomas A, Murray T, Thun M. Cancer statistics. CA Cancer J Clin 2002;52:23-47.
74. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ. Cancer statistics, 2003. CA Cancer J Clin 2003;53:5-26.
75. Armatage P, Doll R. The age distribution of cancer and a multi-stage theory of carcinogenesis. Br J Cancer 1954;8:1-12.
76. Moorman AV, Roman E, Cartwright RA, Morgan CJ. Age-specific incidence rates for cytogenetically-defined subtypes of acute myeloid leukemia. Br J Cancer 2002;86:1061-1063.
77. Gold LS, Slone TH, Manley NB, Ames B. Risk controversy series 3: Misconceptions about the causes of cancer. Vancouver: The Fraser Institute; 2002.
78. Clegg LX, Feuer EJ, Midthune DN, Fay MP, Hankey BF. Impact of reporting delay and reporting error on cancer incidence rates and trends. J Natl Cancer Inst 2002;94:1537-1545.
79. Boffetta P, Nyberg F. Contribution of environmental factors to cancer risk. Br Med Bull 2003;68:71-94.
80. Howard CV, Staats de Yanés G. Telomere length and mortality. Lancet 2003;361:1224.
81. Tomatis L, Huff J, Hertz-Picciotto I. Avoided and avoidable risks of cancer. Carcinogen 1997;18:97-105.
82. Skakkebaek NE, Meyts ER-D, Main KM. Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental impacts. Human Reprod 2001;16:972-978.
83. Zahm SH, Devesa SS. Childhood cancer: overview of incidence trends and environmental carcinogens. Environ Health Perspect 1995;10:177-184.
84. American Cancer Society. The history of cancer, 2004 (http://www.cancer. org/docroot/CRI/content/CRI_2_6x_the_history_of_cancer_72.asp?sitearea=cri).
85. Breast Cancer Society of Canada. Breast cancer history, 2005 (http://www.bcsc.ca/bcsc_html/about/about_historybc.html).
86. Rare Cancer Alliance. Cancer history, 2004 (http://www.rare-cancer.org/ history-of-cancer.html).
87. Cancer Society of New Zealand. The history of cancer, 2004 (http://www.cancernz.org.nz/).
88. Encyclopædia Britannica, 2005 (http://www.britannica.com/eb/ article?tocId=224787).
89. Goldsmith Z. Cancer: a disease of industrialization. Ecologist 1998;28:93-99.
90. Stefansson V. Cancer: disease of civilization? An anthropological and historical study. New York: Hill and Wang; 1960.
91. Bainbridge WS. The cancer problem, 1914 (cited by Stefansson).
92. Bulkley JL. Cancer among primitive tribes. Cancer 1927;4:289-295 (cited by Stefansson).
93. Price WA. Report of an interview with Dr Joseph Herman Romig: nutrition and physical degeneration, 1939 (cited by Stefansson).
94. Berglas A. Cancer: nature, cause and cure. Paris: Pasteur Institute; 1957 (cited by Stefansson).
95. Hoffman FL. Cancer and civilization, speech to Belgian National Cancer Congress at Brussels, 1923 (cited by Stefansson).
96. Shono T, Suita S. Dose-dependent effect of phthalate ester on testicular descent in pre-and post-natal rats. Urol Res 2003;31:293-296.
97. Singleton DW, Khan SA. Xenoestrogen exposure and mechanisms of endocrine disruption. Front Biosci 2003;8:110-118.
98. Waxman DJ. P450 gene induction by structurally diverse xenochemicals: central role of nuclear receptors CAR, PXR, and PPAR. Arch Biochem Biophys 1999;369:11-23.
99. Spink DC, Lincoln DW, Dickerman HW, Gierthy JF. 2,3,7,8- Tetrachlorodibenzo-p-dioxin causes an extensive alteration of 17β-estradiol metabolism in MCF-7 breast tumour cells. Proc Natl Acad Sci USA 1990;87:6917-6921.
100. Kester HA, Bulduk S, van-Toor H, Tibboel D, Meinl W, Glatt H, Falany CN, Coughtrie MW, Schuur AG, Brouwer A, Visser TJ. Potent inhibition of estrogen sulfotransferase by hydroxylated metabolites of polyhalogenated aromatic hydrocarbons reveals alternative mechanism for estrogenic activity of endocrine disrupters. J Clin Endocrinol Metabol 2002;87:1142-1150.
101. Kester HA, Bulduk S, Tibboel D, Meinl W, Glatt H, Falany CN, Coughtrie MWH, Bergman A, Safe SH, Kuiper GGJM. Potent inhibition of oestrogen sulphotransferase by hydroxylated PCB metabolites: a novel pathway explaining the oestrogenic activity of PCBs. Endocrinology 2000;141:1897-1900.
102. Katzenellenbogen JA, Muthyala R. Interactions of exogenous endocrine active substances with nuclear receptors. Pure Appl Chem 2003;75:1797-1817.
103. Report on carcinogens, 11th ed. US Department of Health and Human Services, Public Health Service, National Toxicology Program; 2004.
104. Gray LE, Ostby J, Furr J, Wolf CJ, Lambright C, Parks L, Veeramachaneni DN, Wilson V, Price M, Hotchkiss A, et al. Effects of environmental antiandrogens on reproductive development in experimental animals. Human Reprod Update 2001;7:248-264.
105. Amaral Mendes JJ. The endocrine disrupters: a major medical challenge. Food Chem Toxicol 2002;40:781-788.
106. Tsuda H, Naito A, Kim CK, Fukamachi K, Nomoto H, Moore MA. Carcinogenesis and its modification by environmental endocrine disruptors: in vivo experimental and epidemiological findings. Jpn J Clin Oncol 2003;33:259-270.
107. Hamersa T, van den Brinkb P, Lizzy Mosa L, van der Linden SC, Legler J, Koeman JH, Murk AJ. Estrogenic and esterase-inhibiting potency in rainwater in relation to pesticide concentrations, sampling season and location. Environ Poll 2003;123:47-65.
108. Lohman K, Seigneur C. Atmospheric fate and transport of dioxins: local impacts. Chemosphere 2001;45:161-171.
109. Alcock R, Behnisc PA, Jones K, Hagenmaier H. Dioxin-like PCBs in the environment - human exposure and the significance of sources. Chemosphere 1998;37:1457-1472.
110. IARC. Some organochlorine pesticides. IARC monographs on the evaluation of the carcinogenic risks of chemicals to humans, Vol. 5. Lyon: IARC Press; 1984.
111. De Vos S, Maervoet J, Schepens P, De Schrijver R. Polychlorinated biphenyls in Broiler diets: their digestibility and incorporation in body tissues. Chemosphere 2003;51:7-11.
112. Llobet JM, Domingo JL, Bocio A, Casas C, Teixido A, Muller L. Human exposure to dioxins through the diet in Catalonia, Spain: carcinogenic and non-carcinogenic risk. Chemosphere 2003;50:1193-1200.
113. Shono T, Suita S, Kai H, Yamaguchi Y. The effect of a prenatal androgen disruptor, vinclozolin, on gubernacular migration and testicular descent in rats. J Pediatr Surg 2004;39:213-216.
114. Haavisto T, Nurmela K, Pohjanvirta R, Huuskonen H, El-Gehani F, Paranko J. Prenatal testosterone and luteinizing hormone levels in male rats exposed during pregnancy to 2,3,7,8-tetrachlorodibenzo-p-dioxin and diethylstilbestrol. Mol Cell Endocrinol 2001;178:169-179.
115. Williams K, McKinnell C, Saunders PTK, Walker M, Fisher JS, Turner KJ, Atanassova N, Sharpe M. Neonatal exposure to potent and environmental oestrogens and abnormalities of the male reproductive system in the rat: evidence for importance of the androgen: oestrogen balance and assessment of the relevance to man. Human Reprod Update 2001;7:236-247.
116. Andersen L, Holbech H, Gessbo A, Norrgren L, Petersen GI. Effects of exposure to 17 a-ethinylestradiol during early development on sexual differentiation and induction of vitellogenin in zebrafish (Danio rerio). Comp Biochem Physiol 2003;134:365-374.
117. Anbalagan J, Kanagaraj P, Srinivasan N, Aruldhas MM, Arunakaran J. Effect of polychlorinated biphenyl, Aroclor 1254 on rat epididymis. Indian J Med Res 2003;118:236-242.
118. Hayes T, Haston K, Tsui M, Hoang A, Haeffele C, Vonk A. Herbicides: feminization of male frogs in the wild. Nature 2002;419:895-896.
119. Melnick R, Lucier G, Wolfe M, Hall R, Stancel G, Prins G, Gallo M, Reuhl K, Ho S-M, Brown T. Summary of the National Toxicology Program's report of the endocrine disruptors low-dose peer review. Environ Health Perspect 2002;110:427-431.
120. Chu I, Lecavalier P, Hakansson H, Yagminas A, Valli VE, Poon P, Feeley M. Mixture effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin and polychlorinated biphenyl congeners in rats. Chemosphere 2001;43:807-814.
121. Vom Saal F, Timms BG, Montano MM. Prostate enlargement in mice due to fetal exposure to low doses of oestradiol or diethylstilbestrol and opposite effects at high doses. Proc Natl Acad Sci USA 1997;94:2056-2061.
122. Ames B, Gold L. Environmental pollution, pesticides, and the prevention of cancer: misconceptions. FASEB 1997;11:1041-1052.
123. Ames B, Gold L. The causes and prevention of cancer: the role of environment. Biotherapy 1998;11:205-220.
124. Safe SH. Environmental and dietary estrogens and human health: is there a problem? Environ Health Perspect 1995;103:346-351.
125. Safe SH. Is there an association between exposure to environmental estrogens and breast cancer? Environ Health Perspect 1997;105:675-678.
126. Safe SH. Endocrine disruptors and human health - is there a problem? An update. Environ Health Perspect 2000;108:487-493.
127. Rang HP, Dale MM, Ritter JM. Pharmacology, 3rd ed. London: Churchill Livingston; 1995. Chapter 22, pp 458-459.
128. Hill DE, Slikker W Jr, Helton ED. Transplacental pharmacokinetics and metabolism of diethylstilbestrol and 17 beta-estradiol in the pregnant rhesus monkey. J Clin Endocrinol Metab 1980;50:811-818.
129. Slikker W Jr, Hill DE, Young JF. Comparison of the transplacental pharmacokinetics of 17 beta-estradiol and diethylstilbestrol in the subhuman primate. J Pharmacol Exp Ther 1982;221:173-182.
130. Soliman AS, Wang X, DiGiovanni J, Eissa S, Morad M, Vulimiri S, Mahgoub KG, Johnston DA, Do KA, Seifeldin IA, et al. Serum organochlorine levels and history of lactation in Egypt. Environ Res 2003;92:110-117.
131. Covaci A, Jorens P, Jacquemyn Y, Schepens P. Distribution of PCBs and organochlorine pesticides in umbilical cord and maternal serum. Sci Total Environ 2002;298:45-53.
132. Sala M, Ribas-Fito N, Cardo E, de Muga ME, Marco E, Mazon C, Verdu A, Grimalt JO, Sunyer J. Levels of hexachlorobenzene and other organochlorine compounds in cord blood: exposure across placenta. Chemosphere 2001;43:895-901.
133. Karmaus W, DeKoning EP, Kruse H. Early childhood determinants of organochlorine concentrations in school-aged children. Pediatr Res 2001;50:331-336.
134. Takahashi O, Oishi S. Disposition of orally administered 2,2-bis(4-hydroxyphenyl)propane (bisphenol A) in pregnant rats and the placental transfer to fetuses. Environ Health Perspect 2000;108:931-935.
135. Schecter A, Ryan JJ, Papke O. Decrease in levels and body burden of dioxins, dibenzofurans, PCBs, DDE, and HCB in blood and milk in a mother nursing twins over a thirty-eight month period. Chemosphere 1998;37:1807-1816.
136. Keck A-S, Finley JW. Cruciferous vegetables: cancer protective mechanisms of glucosinolate hydrolysis products and selenium. Integ Cancer Ther 2004;3:5-12.
137. Jaga K, Duvvi H. Risk reduction for DDT toxicity and carcinogenesis through dietary modification. J R Soc Prom Health 2001;121:107-113.
138. Grubbs CJ, Steele VE, Casebolt T, Juliana MM, Eto I, Whitaker LM, Dragnev KH, Kelloff GJ, Lubet RL. Chemoprevention of chemically-induced mammary carcinogenesis by indole-3-carbinol. Anticancer Res Treat 1995;15:709-716.
139. Zeligs MA. Safer estrogen with phytonutrition. Townsend Lett 1999;189:83-88.
140. Bradlow HL, Davis DL, Lin G, Sepkovic D, Tiwari R. Effects of pesticides on the ratio of 16a-hydroxyestrone: a biological marker of breast cancer risk. Environ Health Perspect 1995;103:147-150.
141. Telang NT, Suto A, Wong NY, Osborne MP, Bradlow HL. Induction by the estrogen metabolite, 16-hydroxyestrone, of genotoxic damage and aberrant proliferation in mouse mammary epithelial cells. J Natl Cancer Inst 1992;84:634-638.
142. Suto A, Bradlow HL, Wong GY, Osborne MP, Telang NT. Experimental down regulation of intermediate biomarkers of carcinogenesis in mouse mammary epithelial cells. Breast Cancer Res Treat 1993;27:193-202.
143. Kojima T, Tanaka T, Mori M. Chemoprevention of spontaneous endometrial cancer in female Donryu rats by dietary indole-3-carbinol. Cancer Res 1994;54:1446-1449.
144. Bradlow HL, Michnovicz JJ, Telang NT, Osborne MP. Effect of dietary indole-3-carbinol on estradiol metabolism and spontaneous mammary tumors in mice. Carcinogen 1991;12:1571-1574.
145. Howard CV, Staats de Yanes G. Endocrine disrupting chemicals: a conceptual framework. In: Nicolopolou-Stamati P, Hens L, Howard CV, editors. Environmental health aspects of endocrine disruptors. Dordrecht: Kluwer; 2001. pp 219-250.
146. Vetter W, Scherer G. Variety, structures, GC properties, and persistence of compounds of technical toxaphene (CTTs). Chemosphere 1998;37:2525-2543.
147. Barns S. Oestrogens and their promiscuous receptors: confronting reality. Biochem Soc Trans 2001;29:231-236.
148. Rudel R. Predicting health effects of exposures to compounds with estrogenic activity: methodological issues. Environ Health Perspect 1997;105:655-663.
149. Sharpe RM. Hormones and testis development and the possible adverse effects of environmental chemicals. Toxicol Lett 2001;120:221-232.
150. Sharpe RM. The 'oestrogen hypothesis' - where do we stand now? Int J Androl 2003;26:2-15.
151. Mylchreest E, Sar M, Cattley RC. Disruption of androgen-regulated male reproductive development by di(n-butyl) phthalate during late gestation in rats is different from flutamide. Toxicol Appl Pharmacol 1999;156:81-95.
152. Mylchreest E, Wallace DG, Cattley RC, Foster PMD. Dose-dependent alterations in androgen-regulated male reproductive development in rats exposed to di(n-butyl) phthalate during late gestation. Toxicol Sci 2000;55:143-151.
153. McKinnell C, Atanassova N, Williams K, Fisher JS, Walker M, Turner KJ, Saunders TK, Sharpe RM. Suppression of androgen action and the induction of gross abnormalities of the reproductive tract in male rats treated neonatally with diethylstilbestrol. J Androl 2001;22:323-338.
154. Ribas-Fito N, Sala M, Kogevias M, Sunyer J. Polychlorinated biphenyls (PCBs) and neurological development in children: a systematic review. J Epidemiol Comm Health 2001;55:537-546.
155. Weisskopf M, Anderson H, Hanrahan L. Decreased sex ratio following maternal exposure to polychlorinated biphenyls from contaminated Great Lakes sport-caught fish: a retrospective cohort study. Environ Health 2003;2:2.
156. Herman-Giddens ME, Slora EJ, Wasserman RC. Secondary sexual characteristics and menses in young girls seen in office practice: a study from the Pediatric Research in Office Settings network. Pediatrics 1997;99:505-512.
157. Nohyneka GJ, Fautzb R, Benech-Kiefferc F, Toutain H. Toxicity and human health risk of hair dyes. Food Chem Toxicol 2003;42:517-543.
158. Darbre PD. Under arm cosmetics are a cause of breast cancer hypothesis. Eur J Cancer Prev 2001;10:389-393.
159. Harvey P. Parabens estrogenecity, under arm cosmetics and breast cancer : a perspective on a hypothesis. J Appl Toxicol 2003;23:285-288.
160. Sasco AJ. Epidemiology of breast cancer: an environmental disease? APMIS 2001;109:321-332.
161. Sasco AJ. Breast cancer and the environment. Horm Res 2003;60:50.
162. Lacey JV Jr, Devesa SS, Brinton LA. Recent trends in breast cancer incidence and mortality. Environ Mol Mutagen 2002;39:82-88.
163. Swerdlow AJ. Cancer registration in England and Wales: some aspects relevant to interpretation of the data. J R Stat Soc Series A 1986;149:146-160.
164. Epstien S. Winning the war against cancer: are they even fighting it? Ecologist 1998;28:69.
165. Botha JL, Bray CF, Sankilac R, Parkin DM. Breast cancer incidence and mortality trends in 16 European countries. Eur J Cancer 2003;39:1718-1729.
166. Baquet CR, Commiskey P. Socioeconomic factors and breast carcinoma in multicultural women. Cancer 2000;88(5 Suppl):1256-1264.
167. Banks E. Hormone replacement therapy and the sensitivity and specificity of breast cancer screening: a review. J Med Screen 2001;8:29-34.
168. Patel AD, Bach PB, Kris MG. Lung cancer in US women. A contemporary epidemic. J Am Med Assoc 2004;291:1763-1768.
169. Beral V. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 2003;362(9382):419-427.
170. Le GM, Gomez S, Clarke CA, Glaser SL, West DW. Cancer incidence patterns among Vietnamese in the United States and Ha Noi, Vietnam. Int J Cancer 2002;102:412-417.
171. Leung GM, Thach TQ, Lam TH, Hedley AJ, Foo W, Fielding R, Yip PS, Lau EM, Wong CM. Trends in breast cancer incidence in Hong Kong between 1973 and 1999: an age-period-cohort analysis. Br J Cancer 2002;87:982-988.
172. Høyer AP, Grandjean AP, Jørgensen T, Brock JW, Hartvig HB. Organochlorine exposure and risk of breast cancer. Lancet 1998;352:1816-1820.
173. Key TJ, Verkasalo PK. Endogenous hormones and the aetiology of breast cancer. Breast Cancer Res 1999;1:18-21.
174. Madigan PM, Regina ZG, Benichou J, Byrne C, Hoover RN. Proportion of the breast cancer cases in the United States explained by well-established risk factors. J Natl Cancer Inst 1987;87:1681-1685.
175. Warner M, Eskenazi B, Mocarelli P, Gerthoux PM, Samuels S, Needham L. Serum dioxin concentrations and breast cancer risk in the Seveso Women's Health Study. Environ Health Persp 2002;10:625-628.
176. Stellman SD, Djordjevic MV, Britton JA, Muscat JE, Citron ML, Kemeny M, Busch E, Gong L. Breast cancer risk in relation to adipose concentrations of organochlorine pesticides and polychlorinated biphenyls in Long Island, New York. Cancer Epidemiol Biomark Prev 2000;9:1241-1249.
177. Gammon MD, Wolff MS, Neugut AL, Eng SM, Teitelbaum SL, Britton JA, Terry MB, Levin B, Stellman SD, Kabat G, et al. Environmental toxins and breast cancer on Long Island. II. Organochlorine compound levels in blood. Cancer Epidemiol Biomark Prev 2002;11:686-697.
178. Muscat JE, Britton JA, Djordjevic MV, Citron ML, Kemeny M, Busch-Devereaux E, Pittman B, Stellman SD. Adipose concentrations of organochlorine compounds and breast cancer recurrence in Long Island, New York. Cancer Epidemiol Biomark Prev 2003;12:1474-1478.
179. Helzlsour KJ, Alberg AJ, Huang H-A, Hoffman SC, Strickland PT, Brock JW, Burse VW, Needham LL, Bell DA, Lavigne JA, et al. Serum concentrations of organochlorine compounds and the subsequent development of breast cancer. Cancer Epidemiol Biomark Prev 1999;8:525-532.
180. Zheng T, Holford TR, Mayne ST, Tessari J, Owens PH, Zahm SH, Zhang B, Dubrow R, Ward B, Carter D, et al. Environmental exposure to hexachlorobenzene (HCB) and risk of female breast cancer in Connecticut. Cancer Epidemiol Biomark Prev 1999;8:407-441.
181. Dorgan JF, Brock JW, Rothman N, Needham LL, Miller R, Stephenson HE Jr, Schussler N, Taylor PR. Serum organochlorine pesticides and PCBs and breast cancer risk: results from a prospective analysis (USA). Cancer Causes Control 1999;10:1-11.
182. Demers A, Ayotte P, Brisson J, Dodin S, Robert J, Dewailly E. Plasma concentrations of polychlorinated biphenyls and the risk of breast cancer: a congener-specific analysis. Am J Epidemiol 2002;155:629-635.
183. Demers A, Ayotte P, Brisson J, Dodin S, Robert J, Dewailly E. Risk and aggressiveness of breast cancer in relation to plasma organochlorine concentrations. Cancer Epidemiol Biomark Prev 2000;9:161-166.
184. Ward EM, Schulte P, Grajewski B, Andersen A, Patterson DG Jr, Turner W, Jellum E, Deddens JA, Friedland J, Roeleveld N, et al. Serum organochlorine levels and breast cancer: a nested case-control study of Norwegian women. Cancer Epidemiol Biomark Prev 2000;9:1357-1367.
185. Charlier C, Albert A, Herman P, Hamoir E, Gaspard U, Meurisse M, Plomteux G. Breast cancer and serum organochlorine residues. Occup Environ Med 2003;60:348-351.
186. Hunter DJ, Hankinson SE, Laden F, Colditz GA, Manson JE, Willett WC, Speizer FE, Wolff MS. Plasma organochlorine levels and the risk of breast cancer. N Engl J Med 1997;337:1253-1258.
187. Rattenborg T, Gjermandsen I, Bonefeld-Jørgensen EC. Inhibition of E2-induced expression of BRCA1 by persistent organochlorines. Breast Cancer Res 2002;4, R12 (http://breast-cancer-research.com/content/4/6/R12).
188. Hilakivi-Clarke L. Estrogens, BRCA1, and breast cancer. Cancer Res 2000;60:4993-5001.
189. Zou E, Matsumura F. Long-term exposure to b-hexachlorocyclohexane (b-HCH) promotes transformation and invasiveness of MCF-7 human breast cancer cells. Biochem Pharmacol 2003;66:831-840.
190. Coyle YM. The effect of environment on breast cancer risk. Breast Cancer Res Treat 2004;84:273-288.
191. Martin MB, Reiter R, Pham T, Avellanet YR, Camara J, Lahm M, Pentecost E, Pratap K, Gilmore BA, Divekar S, et al. Estrogen-like activity of metals in MCF-7 breast cancer cells. Endocrinology 2003;14:2425-2436.
192. Johnson MD, Kenney N, Stoica A, Hilakivi-Clarke L, Singh B, Chepko G, Clarke R, Sholler PF, Lirio AA, Foss C, et al. Cadmium mimics the in vivo effects of estrogen in the uterus and mammary gland. Nat Med 2003;9:1081-1084.
193. Laden F, Ishibe N, Hankinson SE, Wolff MS, Gertig DM, Hunter DJ, Kelsey KT. Polychlorinated biphenyls, cytochrome P450 1A1, and breast cancer risk in the Nurses' Health Study. Cancer Epidemiol Biomark Prev 2002;11:1560-1565.
194. Spink BC, Pang S, Pentecost BT, Spink DC. Induction of cytochrome P450 1B1 in MDA-MB-231 human breast cancer cells by non-ortho-substituted polychlorinated biphenyls. Toxicol in Vitro 2002;16:695-704.
195. Høyer AP, Gerdes A-M, Jørgensen T, Rank F, Hartvig HB. Organochlorines, p53 mutations in relation to breast cancer risk and survival. A Danish cohort-nested case-controls study. Breast Cancer Res Treat 2002;71:59-65.
196. Palmer J, Hatch E, Rosenburg C. Risk of breast cancer in women exposed to diethylstilboestrol in utero: preliminary results (United States). Cancer Causes Control 2002;13:753-758.
197. Brown NM, Manzolillo PA, Zhang J-X, Wang J, lamartinere CA. Prenatal TCDD and predisposition to mammary cancer in the rat. Carcinogen 1998;19:1623-1629.
198. Fenton SE, Hamm JT, Birnbaum LS, Youngblood GL. Persistent abnormalities in the rat mammary gland following gestational and lactational exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Toxicol Sci 2002;67:63-74.
199. Markey CM, Luque EH, Munoz de Toro M. In utero exposure to bisphenol A alters the development and tissue organization of the mouse mammary gland. Biol Reprod 2001;65:1215-1223.
200. Sonnenschein C, Soto AM. The society of cells: cancer and control of cell proliferation. New York: Springer; 1999.
201. Soto AM, Sonnenschein C. The somatic mutation theory of cancer: growing problems with the paradigm? BioEssays 2004;26:1097-1107.
202. Boveri T. The origin of malignant tumors. Baltimore, MD: Williams & Wilkins; 1914.
203. Soto AM, Sonnenschein C. Emergentism as a default: cancer as a problem of tissue organization. J Biosci 2005;30:103-118.
204. Prehn RT. The role of mutation in the new cancer paradigm. Cancer Cell Int 2005;5:9, (doi: 10.1186/1475-2867-5-9.
205. Ashby J, Tennant RW. Chemical structure, Salmonella mutagenicity and extent of carcinogenicity as indicators of genotoxic carcinogenesis among 222 chemicals tested in rodents by the U. S. NCI/NTP. Mutat Res 1988;204:17-115.
206. Luch A. Nature and nurture - lessons from chemical carcinogenesis. Nat Rev Cancer 2005;5:113-125.
207. Sonnenschein C, Soto AM. Are times a 'changin' in carcinogenesis? Endocrinology 2004;146:11-12.
208. Maffini MV, Soto AM, Calabro JM, Ucci AA, Sonnenschein C. The stroma as a crucial target in rat mammary gland carcinogenesis. J Cell Sci 2004;117:1495-1502.
209. Crawford DE. Epidemiology of prostate cancer. Urology 2003;62:3-12.
210. Oliver SE, Gunell D, Donovan JL. Comparison of trenes in prostate cancer mortality in England and Wales and the USA. Lancet 2000;355:1788-1789.
211. Quagliaa A, Parodib S, Grosclaudec P, Martinez-Garcia C, Coebergh JW, Vercelli M. Differences in the epidemic rise and decrease of prostate cancer among geographical areas in southern Europe: an analysis of differential trends in incidence and mortality in France, Italy and Spain. Eur J Cancer 2003;39:654-665.
212. Grönberg H. Prostate cancer epidemiology. Lancet 2003;361:859-864.
213. Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J. (eds). Cancer incidence in five continents, Vol. VII. Lyon: IARC; 1997.
214. American Cancer Society. Cancer facts and figures 2003 (http://www.cancer.org/docroot/STT/stt_0.asp).
215. Majeed A, Babb P, Jones J, Quinn M. Trends in prostate cancer incidence, mortality and survival in England and Wales 1971-1998. BJU Int 2000;85:1058-1062.
216. Post PN, Stockton D, Davies TW, Coebergh JW. Striking increase in incidence of prostate cancer in men aged < 60 years without improvement in prognosis. Br J Cancer 1999;79:13-17.
217. Evans HS, Møllera H. Recent trends in prostate cancer incidence and mortality in Southeast England. Eur Urol 2003;43:337-341.
218. Vutuc C, Waldhoer T, Madersbacher S, Mickshe M, Haidinger G. Prostate cancer in Austria: impact of prostate specific antigen test on incidence and mortality. Eur J Cancer Prev 2001;10:425-428.
219. Newby JA, Howard CV, Busby C. An index to aid determination of changes in the age of onset of cancer within different sections of the population in England and Wales, 1971-1999. Unpublished data.
220. Schaid DJ. The complex genetic epidemiology of prostate cancer. Human Mol Genet 2004;13:R103-R121.
221. Homma Y, Kondo Y, Kaneko M, Kitamura T, Nyou WT, Yanagisawa M, Yamamoto Y, Kakizoe T. Promotion of carcinogenesis and oxidative stress by dietary cholesterol in rat prostate. Carcinogen 2004;25:1011-1014.
222. Qin L-Q, Wanga P-Y, Kaneko T, Hoshi K, Sato A. Estrogen: one of the risk factors in milk for prostate cancer. Med Hypoth 2004;62:133-142.
223. Schuurman AG, van den Brandt PA, Dorant E, Goldbohm RA. Animal products, calcium and protein and prostate cancer risk in the Netherlands Cohort Study. Br J Cancer 1999;80:1107-1113.
224. Shirai T, Asamoto M, Takahashi S, Imaida K. Diet and prostate cancer. Toxicology 2002;181-182:89-94.
225. Schuurman AG, van den Brandt PA, Dorant E, Brants HA, Goldbohm RA. Association of energy and fat intake with prostate carcinoma risk: results from the Netherlands Cohort Study. Cancer 1999;86:1019-1027.
226. Li XM, Ganmaa D, Qin LQ, Liu XF, Sato A. The effects of estrogen-like products in milk on prostate and testes. Zhonghua Nan Ke Xue 2003;9:186-190.
227. Männistö S, Pietinen P, Virtanen MJ, Salminen I, Albanes D, Giovannucci E, Virtamo J. Fatty acids and risk of prostate cancer in a nested case-control study in male smokers. Cancer Epidemiol Biomark Prev 2003;12:1422-1428.
228. Stattin P, Lumme S, Tenkanen L, Alfthan H, Jellum E, Hallmans G, Thoresen S, Hakulinen T, Luostarinen T, Lehtinen M, et al. High levels of circulating testosterone are not associated with increased prostate cancer risk: a pooled prospective study. Int J Cancer 2004;108:418-424.
229. Chen C, Weiss NS, Stanczyk FZ, Lewis SK, DiTommaso D, Etzioni R, Barnett MJ, Goodman GE. Endogenous sex hormones and prostate cancer risk. A case-control study nested within the Carotene and Retinol Efficacy Trial. Cancer Epidemiol Biomark Prev 2003;12:1410-1416.
230. Settimi L, Masina A, Andrion A, Axelson O. Prostate cancer and exposure to pesticides in agricultural settings. Int J Cancer 2003;104:458-461.
231. Sharma-Wagner S, Chokkalingam AP, Malker HS, Stone BJ, McLaughlin JK, Hsing AW. Occupation and prostate cancer risk in Sweden. J Occup Environ Med 2000;42:517-525.
232. Dich J, Wiklund K. Prostate cancer in pesticide applicators in Swedish agriculture. Prostate 1998;34:100-112.
233. Potti A, Panwalkar AW, Langness E. Prevalence of pesticide exposure in young males (
234. Ralph JL, Orgebin-Crist M-C, Lareyre J-J, Nelson CC. Disruption of androgen regulation in the prostate by the environmental contaminant hexachlorobenzene. Environ Health Perspect 2003;111:461-466.
235. Tessier DM, Matsumura F. Increased ErbB-2 tyrosine kinase activity, MAPK phosphorylation, and cell proliferation in the prostate cancer cell line LNCaP following treatment by select pesticides. Toxicol Sci 2001;60:38-43.
236. Ritchie JM, Vial SL, Fuortes LJ, Guo H, Reedy VE, Smith EM. Organochlorines and risk of prostate cancer. J Occup Environ Med 2003;45:692-702.
237. Alavanja MC, Samanic C, Dosemeci M, Lubin J, Tarone R, Lynch CF, Knott C, Thomas K, Hoppin JA, Barker J, et al. Use of agricultural pesticides and prostate cancer risk in the Agricultural Health Study cohort. Am J Epidemiol 2003;157:800-814.
238. Janssens J, van Hecke E, Geys H, Bruckers L, Renard D, Molenberghs G. Pesticides and mortality from hormone-dependent cancers. Eur J Cancer Prev 2001;10:459-467.
239. Huyghe E, Matsuda T, Thonneau P. Increasing incidence of testicular cancer worldwide: a review. J Urol 2003;170:5-11.
240. Moller H. Trends in incidence of testicular cancer and prostatic cancer in Denmark. Human Reprod 2001;16:1007-1011.
241. English PB, Goldberg DE, Wolf C, Smith D. Parental and birth characteristics in relation to testicular cancer risk among males born between 1960 and 1995 in California (United States). Cancer Causes Control 2003;14:815-825.
242. Dearnaley DP, Huddart RA, Horwich A. Managing testicular cancer. Br Med J 2001;322:1583-1588.
243. Dos Santos Silva I, Swerdlow AJ, Stiller CA. Incidence of testicular germ-cell malignancies in England and Wales: trends in children compared with adults. Int J Cancer 1999;83:630-634.
244. Hardell L, ran Ohlson CG, Fredrikson M. Occupational exposure to polyvinyl chloride as a risk factor for testicular cancer evaluated in a case-control study. Int J Cancer 1997;73:828-830.
245. Hardell L, Malmqvist N, ran Ohlson CG, Westberg H, Eriksson M. Testicular cancer and occupational exposure to polyvinyl chloride plastics: a case-control study. Int J Cancer 2004;109:425-429.
246. Swerdlow AJ, De Stavola BL, Swanwick MA, Mangtani P, Maconochie NE. Risk factors for testicular cancer: a case-control study in twins. Br J Cancer 1999;80:1098-1102.
247. Rasmussen F, Gunnell D, Ekbom A, Hallqvist J, Tynelius P. Birth weight, adult height, and testicular cancer: cohort study of 337,249 Swedish young men. Cancer Causes Control 2003;14:595-598.
248. Herbst AL, Ulfelder H, Poskanzer DC. Adenocarcinoma of the vagina. Association of maternal stilboestrol therapy with tumour appearance in young women. N Engl J Med 1971;284:878-881.
249. Stroshnitter WC, Noller KL, Hoover RN. Cancer risk in men exposed in utero to diethylstilbestrol. J Natl Cancer Inst 2001;93:545-551.
250. Weir HK, Marrett LD, Kreiger N, Darlington GA, Sugar L. Pre-natal and peri-natal exposures and risk of testicular germ-cell cancer. Int J Cancer 2000;87:438-443.
251. Hoei-Hansen CE, Holm M, Rajpert-De Meyts E, Skakkebaek NE. Histological evidence of testicular dysgenesis in contralateral biopsies from 218 patients with testicular germ cell cancer. J Pathol 2003;200:370-374.
252. Sharpe RM, Skakkaebak NE. Are oestrogens involved in falling sperm counts and disorders of the male reproductive tract? Lancet 1993;341:1392-1395.
253. Dieckmann KP, Endsin G, Pichlmeier U. How valid is the prenatal estrogen excess hypothesis of testicular germ cell cancer? A case control study on hormone-related factors. Eur Urol 2001;40:677-683.
254. Hardell L, Eriksson M. Is the decline of the increasing incidence of non-Hodgkin lymphoma in Sweden and other countries a result of cancer preventive measures? Environ Health Perspect 2003;111:1704-1706.
255. Jakab Z, Balogh E, Kiss C, Olah E. Epidemiologic studies in a population-based childhood cancer registry in northeast Hungary. Med Pediatr Oncol 2002;38:338-344.
256. Quinn M, Babb P, Brock A, Kirby L, Jones J. Cancer trends in England and Wales 1950-1999. Studies on medical and population subjects, Vol. 66. London: Office for National Statistics; 2001.
257. Birch JM. Cancer rates in teens and early 20s rising - more research needed to understand causes, 2004 (http://www.teencancer.org/z/frames2.html).
258. Boutou O, Guizard A-V, Slama R, Pottier D, Spira A. Population mixing and leukaemia in young people around the La Hague nuclear waste reprocessing plant. Br J Cancer 2002;87:740-745.
259. Lancashire R, Sorahan T. Breast-feeding and childhood cancer risks: OSCC data. Br J Cancer 2003;88:1035-1037.
260. Kinlen L, Jiang J, Hemminki K. A case-control study of childhood leukaemia and paternal occupational contact level in rural Sweden. Br J Cancer 2002;86:732-737.
261. Karimi M, Yarmohammadi H. Seasonal variations in the onset of childhood leukemia/lymphoma: April 1996 to March 2000, Shiraz, Iran. Hematol Oncol 2003;21:51-55.
262. McNally RJQ, Alexander FE, Birch JM. Space-time clustering analyses of childhood and acute lymphoblastic leukaemia by immunophenotype. Br J Cancer 2002;87:513-515.
263. Weisglas-Kuperus N, Patandin S, Berbers GAM. Immunologic effects of background exposure to polychlorinated biphenyls and dioxins in Dutch preschool children. Environ Health Perspect 2000;108:1203-1207.
264. ten Tusscher GW, Steerenberg PA, van Loveren H, Vos JG, von dem Borne ADGK, Westra M, van der Slikke JW, Olie K, Pluim HJ, et al. Persistent hematologic and immunologic disturbances in 8-year-old Dutch children associated with perinatal dioxin exposure. Environ Health Perspect 2003;111:1519-1523.
265. Ribas-Fito N, Sala M, Kogevinas M, Sunyer J. Polychlorinated biphenyls (PCBs) and neurological development in children: a systematic review. J Epidemiol Commun Health 2001;55:537-546.
266. van Wijngaarden E, Stewart PA, Olshan AF, Savitz D, Bunin DR. Parental occupational exposure to pesticides and childhood brain cancer. Am J Epidemiol 2003;157:989-997.
267. Ma X, Buffler PA, Gunier RB, Dahl G, Smith MT, Reinier K, Reynolds P. Critical windows of exposure to household pesticides and risk of childhood leukemia. Environ Health Perspect 2002;110:955-960.
268. Anderson LM, Bhalchandra AD, Fear NT, Roman E. Critical windows of exposure for children's health: cancer in human epidemiological studies and neoplasms in experimental animal models. Environ Health Perspect 2000;108:573-594.
269. von Ehrenstein OS, Tamburlini G, Ebi KL, Bertollini R. Children's environmental health: the rationale for a precautionary approach. Rome: World Health Organization, Regional Office for Europe, European Center for Environment and Health; 2002.
270. Dolk H, Vrijheid M. The impact of environmental pollution on congenital anomalies. Br Med Bull 2003;68:25-45.
271. Pryor JL, Hughes C, Foster W, Hales BF, Robaire B. Critical windows of exposure for children's health: the reproductive system in animals and humans. Environ Health Perspect 2000;108:491-503.
272. Hajek RA, Robertson AD, Johnston DA. During development, 17alpha-estradiol is a potent oestrogen and carcinogen. Environ Health Perspect 1997;105:577-581.
273. Vom Saal F, Montano M, Wang M. Sexual differentiation in mammals. In: Colborn T, Clement C, editors. Chemically induced alterations in sexual and functional development: the wildlife/human connection. Princeton, NJ: Princeton Scientific Publishing; 1992. pp 17-83.
274. Jacobson JL, Jacobson SW. Intellectual impairment in children exposed to polychlorinated biphenyls in utero. N Engl J Med 1996;335:783-789.
275. Birnbaum LS, Fenton SE. Cancer and developmental exposure to endocrine disruptors. Environ Health Perspect 2003;111:389-394.
276. Shu XO, Stewart P, Wen WQ, Han D, Potter JD, Buckley JD, Heineman E, Robison LL. Parental occupational exposure to hydrocarbons and risk of acute lymphocytic leukemia in offspring. Cancer Epidemiol Biomark Prev 1999;8:783-791.
277. Freedman DM, Stewart P, Kleinerman RA, Wacholder S, Hatch EE, Tarone RE, Robison LL, Linet MS. Household solvent exposures and childhood acute lymphoblastic leukemia. Am J Pub Health 2001;91:564-567.
278. Alexander FE, Patheal SL, Biondi AB, Brandalise S, Cabrera ME, Chan LC, Chen Z, Cimino G, Cordoba JC, Gu LJ, et al. Transplacental chemical exposure and risk of infant leukemia with MLL gene fusion. Cancer Res 2001;61:2542-2546.
279. Meinert R, Schuz J, Kaatsch P, Kaletsch U, Kaatsch P, Michaelis J. Leukemia and non-Hodgkin's lymphoma in childhood and exposure to pesticides: results of a register-based case-control study in Germany. Am J Epidemiol 2000;7:639-646.
280. Pershagen G. Childhood cancer and malignancies other than lung cancer related to passive smoking. Mutat Res 1989;222:129-135.
281. Hemminki K, Gissler M, Toukomaa H. Exposure to female hormone drugs during pregnancy: effect on malformations and cancer. Br J Cancer 1999;80:1092-1097.
282. Emmen JM, McLuskey A, Adham IM, Engel W, Verhoef-Post M, Themmen AP, Grootegoed JA, Brinkmann AO. Involvement of insulin-like factor 3 (Insl3) in diethylstilbestrol-induced cryptorchidism. Endocrinology 2000;141:846-849.
283. Hsieh CC, Lambe M, Trichopoulos D, Ekbom A, Akre O, Adami HO. Early life exposure to oestrogen and testicular cancer risk: evidence against an aetiological hypothesis. Br J Cancer 2002;86:1362-1366.
284. Branum AM, Collman GW, Correa A, Keim SA, Kessel W, Kimmel CA, Klebanoff MA, Longnecker MP, Mendola P, Rigas M, et al. The National Children's Study of environmental effects on child health and development. Environ Health Perspect 2003;111:642-646.
285. Longnecker MP, Bellinger DC, Crews D, Eskenazi B, Silbergeld EK, Woodruff TJ, Susser ES. An approach to assessment of endocrine disruption in the National Children's Study. Environ Health Perspect 2003;111:1691-1697.
286. Dip R, Hegglin D, Deplazes P, Dafflon O, Koch H, Naegeli H. Age- and sex-dependent distribution of persistent organochlorine pollutants in urban foxes. Environ Health Perspect 2003;111:1608-1612.
287. Lackmann GM. Polychlorinated biphenyls and hexachlorobenzene in full-term neonates. Reference values updated. Biol Neonate 2002;81:82-85.
288. Beebe LE, Kim YE, Amin S, Riggs CW, Kovatch RM, Anderson LM. Comparison of transplacental and neonatal initiation of mouse lung and liver tumors by N-nitrosodimethylamine (NDMA) and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and promotability by a polychlorinated biphenyls mixture (Aroclor1254). Carcinogenesis 1993;14:1545-1548.
289. Lackmann GM, Angerer J, Töllner U. Parental smoking and neonatal serum levels of polychlorinated biphenyls and hexachlorobenzene. Pediatr Res 2000;47:598-601.
290. Cantor KP, Strickland PT, Brock JW, Bush D, Helzlsouer K, Needham LL, Zahm SH, Comstock GW, Rothman N. Risk of non-Hodgkin's lymphoma and prediagnostic serum organochlorines: df-hexachlorocyclohexane, chlordane/heptachlor-related compounds, dieldrin, and hexachlorobenzene. Environ Health Perspect 2003;111:179-183.
291. Hardell L, Eriksson M, Nordstrom M. Exposure to pesticides as risk factor for non-Hodgkin's lymphoma and hairy cell leukemia: pooled analysis of two Swedish case-control studies. Leuk Lymphoma 2002;43:1043-1049.
292. Hardell L, Eriksson M, Lindstrom G, Van Bavel B, Linde A, Carlberg M, Liljegren G. Case-control study on concentrations of organohalogen compounds and titers of antibodies to Epstein-Barr virus antigens in the etiology of non-Hodgkin lymphoma. Leuk Lymphoma 2001;42:619-629.
293. Buckley JD, Meadows AT, Kadin ME, Le Beau MM, Siegel S, Robison LL. Pesticide exposures in children with non-Hodgkin lymphoma. Cancer 2000;89:2315-2321.
294. Beiderbeck AB, Holly EA, Sturkenboom MCJM, Coebergh JW, Stricker BHCh, Leufkens HGM. No increased risk of non-Hodgkin's lymphoma with steroids, estrogens and psychotropics. Cancer Causes Control 2003;14:639-644.
295. Clarke CA, Glaser SL. Changing incidence of non-Hodgkin lymphomas in the United States. Cancer 2002;94:2015-2023.
296. Hardell L, Eriksson M. A case-control study of non-Hodgkin lymphoma and exposure to pesticides. Cancer 1999;86:729-731.
297. Zahm SH, Weisenburger DD, Saal RC, Vaught JB, Babbitt PA, Blair A. The role of agricultural pesticide use in the development of non-Hodgkin's lymphoma in women. Arch Environ Health 1993;48:353-358.
298. Thornton J. Pandora's poison: chlorine, health and a new environmental strategy. Cambridge, MA: MIT Press; 2000.
299. Rothman N, Cantor KP, Blair A, Bush D, Brock JW, Helzlsouer K, Zahm SH, Needham LL, Pearson GR, Hoover RN, et al. A nested case-control study of non-Hodgkin lymphoma and serum organochlorine residues. Lancet 1997;350:240-244.
300. Hardell L, Lindstom G, van Bavel B, Hardell K, Linde A, Carlberg M, Liljegren G. Adipose tissue concentrations of dioxins and dibenzofurans, titers of antibodies to Epstein-Barr virus antigen and the risk for non-Hodgkin lymphoma. Environ Res 2001;Section A 87:99-107.
301. Svensson BG, Mikoczy Z, Stromberg U, Hagmar L. Mortality and cancer incidence among Swedish fishermen with a high dietary intake of persistent organochlorine compounds. Scand J Work Environ Health 1995;21:106-115.
302. Department of Health. NHS Cancer Plan. A plan for investment, a plan for reform, 2000 (http://www.dh.gov.uk/PublicationsAndStatistics/Publications/ PublicationsPolicyAndGuidance/PublicationsPolicy AndGuidanceArticle/fs/en? CONTENT_ID=4009609&chk=n4LXTU).
303. Wilson CM, Tobin S, Young RC. The exploding worldwide cancer burden: the impact of cancer on women. Int J Gynecol Cancer 2004;14:1-11.
304. Nelson R. Childhood cancer survivors face long-term complications. Lancet 2003;362:884.
305. Ariffin H. Long-term side effects of childhood cancer therapy. J Paediat Obstet Gynaecol 2003;29:5-9.
306. Reid U. Problems of infertility following cancer therapy in childhood and adolescence. Eur J Oncol Nurs 2000;4:171-175.
307. Humpl T, Fritsche M, Bartels U, Gutjahr P. Survivors of childhood cancer for more than twenty years. Acta Oncol 2001;40:44-49.
308. Neglia JP, Friedman DL, Yasui Y, Mertens AC, Hammond S, Stovall M, Donaldson SS, Meadows AT, Robison LL. Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study. J Natl Cancer Inst 2001;93:618-629.
309. Katikireddi V. 100 000 children die needlessly from cancer every year. Br Med J 2004;328:422.
310. NHS Executive. Expenditure on cancer research 1995/96. Leeds: NHS Executive; 1996.
311. Department of Health. NHS Cancer Plan. Three year progress report, maintaining the momentum. Publications and statistics, 2004 (http://www.dh.gov. uk/PublicationsAndStatistics/Publications/PublicationsPolicyAndGuidance/ PublicationsPolicyAndGuidanceArticle/fs/en?CONTENT_ID=4066438&chk=SanPzf).
312. Dockerty JD, Skegg DCG, Williams SM. Economic effects of childhood cancer on families. J Paediatr Child Health 2003;39:254-258.
313. Lansky SB, Cairns NU, Clark GM, Lowman J, Miller L, Trueworthy R. Childhood cancer: non-medical costs of the illness. Cancer 1979;43:403-408.
314. Bodkin CM, Pigott TJ, Mann JR. Financial burden of childhood cancer. Br Med J 1982;284:1542-1544.
315. World Health Organization. Declaration; Third Ministerial Conference on Environment and Health. London, 16-18 June 1999 (http://www.euro.who.int/ Document/E69046.pdf).
316. Shea KM. Pediatric exposure and potential toxicity of phthalate plasticizers. Pediatrics 2003;111:1467-1474.